David Diemert, MD, FRCP(C)

Director, Clinical Trials

Dr. David Diemert is director of vaccine clinical development at the Sabin Vaccine Institute, which he joined in 2005.  Dr. Diemert is also an assistant professor in the Department of Microbiology, Immunology and Tropical Medicine at The George Washington University School of Medicine.  Dr. Diemert provides direct oversight for vaccine trials sponsored by Sabin, both in the United States and in Brazil.  His work in Brazil has involved preparing a trial site in partnership with the Fundação Oswaldo Cruz (FIOCRUZ), which has included establishing a clinic in a rural area of Brazil, assembling and training a Brazilian clinical trials team, establishing quality laboratory facilities at the field site, and conducting preparatory studies of helminth epidemiology and immunology.  Prior to joining the HHVI, Dr. Diemert worked for four years at the Malaria Vaccine Development Branch of the National Institute of Allergy and Infectious Diseases, where he was responsible for conducting clinical trials of novel malaria vaccines, both in the United States and in Mali, West Africa.  Dr. Diemert earned his medical degree from the University of Alberta in Edmonton, Canada, and completed residency and fellowship training at McGill University in Montréal.  He is a Fellow of the Royal College of Physicians (Canada) with certification in the specialties of internal medicine, infectious diseases and medical microbiology. Additionally, he received training in clinical tropical medicine through the University of Alabama at Birmingham's Gorgas Course in Lima, Peru.